Insights from Industry RSS Feed - Insights from Industry

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Gaucher disease: an interview with Dr Clement Olivier, Shire

Gaucher disease: an interview with Dr Clement Olivier, Shire

Gaucher disease is the most common condition within a family of rare diseases known as the lysosomal storage diseases. The disease causes lipids to accumulate in cells, which is why it is referred to as a storage disorder. The accumulation occurs mainly in the spleen, liver, and bones, but may also occur in the lungs, heart, and central nervous system. [More]
Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Prescription drug abuse is an extremely complex problem with no single solution. For example, the very same medications that are so critical for alleviating pain in legitimate patients could easily be diverted and misused by other people. [More]
Stages of symptoms in schizophrenia: an interview with Dr. Mark Opler, ProPhase

Stages of symptoms in schizophrenia: an interview with Dr. Mark Opler, ProPhase

I think there's a perception that schizophrenia is principally a disorder that involves hallucinations such as hearing voices, seeing things and believing things that aren't real. These are indeed part of the phenomenon, but the condition is much broader than that. [More]
Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision loss in the industrialized world. [More]
Aging healthily: an interview with Dr. Jack Watters, Vice President for External Medical Affairs, Pfizer

Aging healthily: an interview with Dr. Jack Watters, Vice President for External Medical Affairs, Pfizer

Get Old was developed by Pfizer in 2012 to challenge misperceptions about aging and foster a candid conversation around aging. Our goal for the program was to redefine what it means to “get old” and encourage people to adopt healthy behaviors to age the way they want. [More]
Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

The pacemaker or ICD unit, which is the implanted box or generator i.e. the electrical component of the device that's implanted in the chest, usually lasts between seven to 10 years before the generator’s battery is depleted. [More]
Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring is the ability to follow patients who have implantable pacemakers or defibrillators from home. This technology was introduced in the U.S. in 2001 so it’s been available for close to 15 years. [More]
Cognitive impairment communication: an interview with Marc Wortmann, Executive Director, Alzheimer’s Disease International (ADI)

Cognitive impairment communication: an interview with Marc Wortmann, Executive Director, Alzheimer’s Disease International (ADI)

Cognitive impairment is the loss of brain functions like short and long term memory, the ability to plan ahead or conduct more complicated intellectual tasks. [More]
Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs. [More]
Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

Tackling rising healthcare costs: an interview with Professor Graeme Currie, Warwick Business School

I think the main reason involves the impact of an aging population, some of whom age healthily, but many of whom, unhealthily, particularly those from poorer sectors of society. [More]
New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

Traditionally, the most commonly used medical devices for spinal fusion procedures have been pedicle screws and rods, and interbody cages or spacers. Each are coupled with bone grafts and limit movement while the area being fused heals. [More]
Botanical dietary supplement screening with NMR and MS – an interview with Kim Colson

Botanical dietary supplement screening with NMR and MS – an interview with Kim Colson

My name is Kim Colson. I’m the Business Development Manager for Bruker Biospin, and right now my group is focusing on the botanical and herbal products and dietary supplements industry, and bringing new tools to that industry that will help to meet their needs for quality control assurance. [More]
Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

During a flare-up, symptoms of a patient’s COPD worsen significantly, and breathing becomes more difficult. A persistent increase in shortness of breath, cough and sputum production are typical symptoms. [More]
Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Gaston Picchio outlines the major findings of the recent report published by The Economist Intelligence Unit (EIU): ‘Tackling hepatitis C: Moving towards an integrated policy approach’ [More]
Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

The more connections are made between genes, disease and drugs, and the more that we continue to understand about those connections, the more critical genetic testing will become in modern medicine. [More]
Pain control in osteoarthritis patients: an interview with Dr. Clarence Young, Chief Medical Officer and John Vavricka, President and CEO, Iroko Pharmaceuticals

Pain control in osteoarthritis patients: an interview with Dr. Clarence Young, Chief Medical Officer and John Vavricka, President and CEO, Iroko Pharmaceuticals

Osteoarthritis (OA) is one of the most common causes of disability, and inadequate pain control can lead to joint stiffness that may impair mobility for patients. [More]
Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Lysosomes are subcellular organelles that are present in most cells, with the major exception of red blood cells. [More]
Treating ulcerative colitis and Crohn’s disease: an interview with Dr. Stephen Hanauer, Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine

Treating ulcerative colitis and Crohn’s disease: an interview with Dr. Stephen Hanauer, Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine

Ulcerative colitis and Crohn’s disease are idiopathic (we don’t know the cause) inflammatory diseases (IBD) of the colon and/or small bowel. They are chronic in that we do not have a medical cure and are differentiated from IBS (irritable bowel syndrome) by inflammation that causes ulcerations of the GI tract. [More]
NMR spectroscopy for in-vitro diagnostic research: an interview with Dr. Manfred Spraul, Director of NMR Applications, Bruker BioSpin

NMR spectroscopy for in-vitro diagnostic research: an interview with Dr. Manfred Spraul, Director of NMR Applications, Bruker BioSpin

Our aim is to open new fields to NMR where we haven’t been before. Because of the extreme stability of our instruments, we can now really think about new applications: going to hospitals, going to food companies and just placing an instrument there that works completely under automation. [More]
Preventing antibiotic side effects: an interview with Florence Séjourné, CEO, Da Volterra

Preventing antibiotic side effects: an interview with Florence Séjourné, CEO, Da Volterra

Like all drugs, antibiotics can have side-effects when administered to people. The most common (and often benign) side effect people experience when taking antibiotics is “associated diarrhea”. This illustrates the fact that antibiotics have an impact on the intestine! [More]